Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study.

ABSTRACT:

Objective

Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by unpredictable flares of disease activity and irreversible damage to multiple organ systems. An earlier study showed that SLE patients carrying an interferon (IFN) gene expression signature in blood have elevated serum levels of IFN-regulated chemokines. These chemokines were associated with more-severe and active disease and showed promise as SLE disease activity biomarkers. This study was designed to validate IFN-regulated chemokines as biomarkers of SLE disease activity in 267 SLE patients followed up longitudinally.

Methods

To validate the potential utility of serum chemokine levels as biomarkers of disease activity, we measured serum levels of CXCL10 (IFNgamma-inducible 10-kd pr

SUBMITTER: Bauer JW 

PROVIDER: S-EPMC2842939 | biostudies-literature | 2009 Oct

REPOSITORIES: biostudies-literature